Ader M, Ni T C, Bergman R N
Department of Physiology and Biophysics, University of Southern California School of Medicine, Los Angeles 90033, USA.
J Clin Invest. 1997 Mar 15;99(6):1187-99. doi: 10.1172/JCI119275.
Glucose tolerance is determined by both insulin action and insulin-independent effects, or "glucose effectiveness," which includes glucose-mediated stimulation of glucose uptake (Rd) and suppression of hepatic glucose output (HGO). Despite its importance to tolerance, controversy surrounds accurate assessment of glucose effectiveness. Furthermore, the relative contributions of glucose's actions on Rd and HGO under steady state and dynamic conditions are unclear. We performed hyperglycemic clamps and intravenous glucose tolerance tests in eight normal dogs, and assessed glucose effectiveness by two independent methods. During clamps, glucose was raised to three successive 90-min hyperglycemic plateaus by variable labeled glucose infusion rate; glucose effectiveness (GE) was quantified as the slope of the dose-response relationship between steady state glucose and glucose infusion rate (GE[CLAMP(total)]), Rd (GE[CLAMP(uptake)]) or HGO (GE[CLAMP(HGO)]). During intravenous glucose tolerance tests, tritiated glucose (1.2 microCi/kg) was injected with cold glucose (0.3 g/kg); glucose and tracer dynamics were analyzed using a two-compartment model of glucose kinetics to obtain Rd and HGO components of glucose effectiveness. All experiments were performed during somatostatin inhibition of islet secretion, and basal insulin and glucagon replacement. During clamps, Rd rose from basal (2.54+/-0.20) to 3.95+/-0.54, 6.76+/-1.21, and 9.48+/-1.27 mg/min per kg during stepwise hyperglycemia; conversely, HGO declined to 2.06+/-0.17, 1.17+/-0.19, and 0.52+/-0.33 mg/min per kg. Clamp-based glucose effectiveness was 0.0451+/-0.0061, 0.0337+/-0.0060, and 0.0102+/-0.0009 dl/min per kg for GE[CLAMP(total)], GE[CLAMP(uptake)], and GE[CLAMP(HGO)], respectively. Glucose's action on Rd dominated overall glucose effectiveness (72.2+/-3.3% of total), a result virtually identical to that obtained during intravenous glucose tolerance tests (71.6+/-6.1% of total). Both methods yielded similar estimates of glucose effectiveness. These results provide strong support that glucose effectiveness can be reliably estimated, and that glucose-stimulated Rd is the dominant component during both steady state and dynamic conditions.
葡萄糖耐量由胰岛素作用和非胰岛素依赖性效应(即“葡萄糖效能”)共同决定,后者包括葡萄糖介导的葡萄糖摄取刺激(Rd)和肝葡萄糖输出抑制(HGO)。尽管其对耐量很重要,但围绕葡萄糖效能的准确评估仍存在争议。此外,在稳态和动态条件下,葡萄糖对Rd和HGO作用的相对贡献尚不清楚。我们对8只正常犬进行了高血糖钳夹和静脉葡萄糖耐量试验,并通过两种独立方法评估葡萄糖效能。在钳夹期间,通过可变的标记葡萄糖输注速率将葡萄糖升至三个连续的90分钟高血糖平台期;葡萄糖效能(GE)被量化为稳态葡萄糖与葡萄糖输注速率(GE[CLAMP(总量)])、Rd(GE[CLAMP(摄取)])或HGO(GE[CLAMP(HGO)])之间剂量反应关系的斜率。在静脉葡萄糖耐量试验期间,将氚标记葡萄糖(1.2微居里/千克)与冷葡萄糖(0.3克/千克)一起注射;使用葡萄糖动力学的两室模型分析葡萄糖和示踪剂动力学,以获得葡萄糖效能的Rd和HGO成分。所有实验均在生长抑素抑制胰岛分泌以及基础胰岛素和胰高血糖素替代的情况下进行。在钳夹期间,随着逐步高血糖,Rd从基础值(2.54±0.20)升至3.95±0.54、6.76±1.21和9.48±1.27毫克/分钟/千克;相反,HGO降至2.06±0.17、1.17±0.19和0.52±0.33毫克/分钟/千克。基于钳夹的葡萄糖效能,GE[CLAMP(总量)]、GE[CLAMP(摄取)]和GE[CLAMP(HGO)]分别为0.0451±0.0061、0.0337±0.0060和0.0102±0.0009分升/分钟/千克。葡萄糖对Rd的作用主导了总体葡萄糖效能(占总量的72.2±3.3%),这一结果与静脉葡萄糖耐量试验获得的结果几乎相同(占总量的71.6±6.1%)。两种方法得出的葡萄糖效能估计值相似。这些结果有力支持了葡萄糖效能可以可靠估计,并且葡萄糖刺激的Rd在稳态和动态条件下都是主要成分。